TÀI LỆU THAM KHẢO
91. Odenbreit S., Till M., Hofreuter D., Faller G., Haas R. Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue. Mol. Microbiol. 1999;31:1537–1548.
92. Odenbreit S., Faller G., Haas R. Role of the alpAB proteins and lipopolysaccharide in adhesion of Helicobacter pylori to human gastric tissue. Int. J. Med. Microbiol. 2002;292:247–256.
93. Mahdavi J., Sondén B., Hurtig M., Olfat F.O., Forsberg L., Roche N., Ångström J., Larsson T., Teneberg S., Karlsson K.A., et al. Helicobacter pylori SabA Adhesin in Persistent Infection and Chronic Inflammation. Science. 2002;297:573–578.
94. Walz A., Odenbreit S., Mahdavi J., Borén T., Ruhl S. Identification and characterization of binding properties of Helicobacter pylori by glycoconjugate arrays. Glycobiology. 2005;15:700–708.
95. Hirmo S., Kelm S., Schauer R., Nilsson B., Wadström T. Adhesion of Helicobacter pylori strains to α-2,3-linked sialic acids. Glycoconj. J. 1996;13:1005–1011.
96. Frame S., Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 2001;359:1–16
97. Ishijima N., Suzuki M., Ashida H., Ichikawa Y., Kanegae Y., Saito I., Borén T., Haas R., Sasakawa C., Mimuro H. BabA-mediated Adherence Is a Potentiator of the Helicobacter pylori Type IV Secretion System Activity. J. Biol. Chem. 2011;286:25256–25264.
98. Backert S., Tegtmeyer N., Fischer W. Composition, structure and function of the Helicobacter pylori cag pathogenicity island encoded type IV secretion system. Future Microbiol. 2015;10:955–965.
99. Hatakeyama M. Structure and function of Helicobacter pylori caga, the first-identified bacterial protein involved in human cancer. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2017;93:196–219.
100. Kaplan-Türköz B., Jiménez-Soto L.F., Dian C., Ertl C., Remaut H., Louche A., Tosi T., Haas R., Terradot L. Structural insights into Helicobacter pylori oncoprotein CagA interaction with β1 integrin. Proc. Natl. Acad. Sci. USA. 2012;109:14640–14645.
101. Jiménez-Soto L.F., Kutter S., Sewald X., Ertl C., Weiss E., Kapp U., Rohde M., Pirch T., Jung K., Retta S.F., et al. Helicobacter pylori type IV secretion apparatus exploits β1 integrin in a novel RGD-independent manner. PLoS Pathog. 2009;5:e1000684.
102. Hatakeyama M. Helicobacter pylori CagA and gastric cancer: A paradigm for hit-and-run carcinogenesis. Cell Host Microbe. 2014;15:306–316.
103. Higashi H., Tsutsumi R., Fujita A., Yamazaki S., Asaka M., Azuma T., Hatakeyama M. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl. Acad. Sci. USA. 2002;99:14428–14433.
104. Figueiredo C., Machado J.C., Yamaoka Y. Pathogenesis of Helicobacter pylori Infection. Helicobacter. 2005;10:14–20.
105. Churin Y., Al Ghoul L., Kepp O., Meyer T.F., Birchmeier W., Naumann M. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J. Cell Biol. 2003;161:249–255.
106. Suzuki M., Mimuro H., Kiga K., Fukumatsu M., Ishijima N., Morikawa H., Nagai S., Koyasu S., Gilman R.H., Kersulyte D., et al. Helicobacter pylori CagA Phosphorylation-Independent Function in Epithelial Proliferation and Inflammation. Cell Host Microbe. 2009;5:23–34.
107. Mimuro H., Suzuki T., Tanaka J., Asahi M., Haas R., Sasakawa C. Grb2 Is a Key Mediator of Helicobacter pylori CagA Protein Activities. Mol. Cell. 2002;10:745–755.
108. Franco A.T., Johnston E., Krishna U., Yamaoka Y., Israel D.A., Nagy T.A., Wroblewski L.E., Piazuelo M.B., Correa P., Peek R.M., Jr. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res. 2008;68:379–387.
109. Saadat I., Higashi H., Obuse C., Umeda M., Murata-Kamiya N., Saito Y., Lu H., Ohnishi N., Azuma T., Suzuki A., et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature. 2007;447:330–333.
110. Murata-Kamiya N., Kurashima Y., Teishikata Y., Yamahashi Y., Saito Y., Higashi H., Aburatani H., Akiyama T., Peek R.M., Jr., Azuma T., et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene. 2007;26:4617–4626.
111. Palrasu M., Zaika E., Paulrasu K., Gokulan R.C., Suarez G., Que J., El-Rifai W., Peek R.M., Garcia-Buitrago M., Zaika A.I. Helicobacter pylori pathogen inhibits cellular responses to oncogenic stress and apoptosis. PLoS Pathog. 2022;18:e1010628.
112. Ohnishi N., Yuasa H., Tanaka S., Sawa H., Miura M., Matsui A., Higashi H., Musashi M., Iwabuchi K., Suzuki M., et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl. Acad. Sci. USA. 2008;105:1003–1008.
113. Viala J., Chaput C., Boneca I.G., Cardona A., Girardin S.E., Moran A.P., Athman R., Memet S., Huerre M.R., Coyle A.J., et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 2004;5:1166–1174.
114. Grubman A., Kaparakis M., Viala J., Allison C., Badea L., Karrar A., Boneca I.G., Le Bourhis L., Reeve S., Smith I.A., et al. The innate immune molecule, NOD1, regulates direct killing of Helicobacter pylori by antimicrobial peptides 94. Cell Microbiol. 2010;12:626–639.
115. Suarez G., Romero-Gallo J., Piazuelo M.B., Wang G., Maier R.J., Forsberg L.S., Azadi P., Gomez M.A., Correa P., Peek R.M. Modification of Helicobacter pylori peptidoglycan enhances NOD1 activation and promotes cancer of the stomach. Cancer Res. Am. Assoc. Cancer Res. Inc. 2015;75:1749–1759.
116. Sorbara M.T., Ellison L.K., Ramjeet M., Travassos L.H., Jones N.L., Girardin S.E., Philpott D.J. The protein ATG16L1 suppresses inflammatory cytokines induced by the intracellular sensors Nod1 and Nod2 in an autophagy-independent manner. Immunity. 2013;39:858–873.
117. Harper C.G., Feng Y., Xu S., Taylor N.S., Kinsel M., Dewhirst F.E., Paster B.J., Greenwell M., Levine G., Rogers A., et al. Helicobacter cetorum sp. nov., a Urease-positive Helicobacter species isolated from dolphins and whales. J. Clin. Microbiol. 2002;40:4536–4543.
118. Reyrat J.M., Lanzavecchia S., Lupetti P., De Bernard M., Pagliaccia C., Pelicic V., Charrel M., Ulivieri C., Norais N., Ji X., et al. 3D imaging of the 58 kDa cell binding subunit of the Helicobacter pylori cytotoxin. J. Mol. Biol. 1999;290:459–470.
119. McClain M.S., Iwamoto H., Cao P., Vinion-Dubiel A.D., Li Y., Szabo G., Shao Z., Cover T.L. Essential role of a GXXXG motif for membrane channel formation by Helicobacter pylori vacuolating toxin. J. Biol. Chem. 2003;278:12101–12108.
120. González-Rivera C., Gangwer K.A., McClain M.S., Eli I.M., Chambers M.G., Ohi M.D., Lacy D.B., Cover T.L. Reconstitution of Helicobacter pylori VacA toxin from purified components. Biochemistry. 2010;49:5743–5752.
121. Torres V.J., Ivie S.E., McClain M.S., Cover T.L. Functional properties of the p33 and p55 domains of the Helicobacter pylori vacuolating cytotoxin. J. Biol. Chem. 2005;280:21107–21114.
122. Gupta V.R., Patel H.K., Kostolansky S.S., Ballivian R.A., Eichberg J., Blanke S.R. Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA. PLoS Pathog. 2008;4:e1000073.
123. Ricci V., Galmiche A., Doye A., Necchi V., Solcia E., Boquet P. High cell sensitivity to Helicobacter pylori VacA toxin depends on a GPI-anchored protein and is not blocked by inhibition of the clathrin-mediated pathway of endocytosis. Mol. Biol. Cell. 2000;11:3897–3909.
124. Oldani A., Cormont M., Hofman V., Chiozzi V., Oregioni O., Canonici A., Sciullo A., Sommi P., Fabbri A., Ricci V., et al. Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells. PLoS Pathog. 2009;5:e1000603.
125. gauthier N.C., Monzo P., Gonzalez T., Doye A., Oldani A., Gounon P., Ricci V., Cormont M., Boquet P. Early endosomes associated with dynamic F-actin structures are required for late trafficking of H. pylori VacA toxin. J. Cell Biol. 2007;177:343–354.
126. Yamasaki E., Wada A., Kumatori A., Nakagawa I., Funao J., Nakayama M., Hisatsune J., Kimura M., Moss J., Hirayama T. Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic proteins Bax and Bak, leading to cytochrome c release and cell death, independent of vacuolation. J. Biol. Chem. 2006;281:11250–11259.
127. Galmiche A., Rassow J., Doye A., Cagnol S., Chambard J.C., Contamin S., De Thillot V., Just I., Ricci V., Solcia E., et al. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J. 2000;19:6361–6370.
128. Jain P., Luo Z.Q., Blanke S.R. Helicobacter pylori vacuolating cytotoxin A (VacA) engages the mitochondrial fission machinery to induce host cell death. Proc. Natl. Acad. Sci. USA. 2011;108:16032–16037.
129. Atherton J.C., Cao P., Peek R.M., Tummuru M.K.R., Blaser M.J., Cover T.L. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 1995;270:17771–17777.
130. Bakhti S.Z., Latifi-Navid S., Mohammadi S., Zahri S., Bakhti F.S., Feizi F., Yazdanbod A., Siavoshi F. Relevance of Helicobacter pylori vacA 3′-end Region Polymorphism to Gastric Cancer. Helicobacter. 2016;21:305–316.
131. Soyfoo D.M., Doomah Y.H., Xu D., Zhang C., Sang H.M., Liu Y.Y., Zhang G.X., Jiang J.X., Xu S.F. New genotypes of Helicobacter pylori VacA d-region identified from global strains. BMC Mol. Cell Biol. 2021;22:4.
132. McClain M.S., Cao P., Iwamoto H., Vinion-Dubiel A.D., Szabo G., Shao Z., Cover T.L. A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J. Bacteriol. 2001;183:6499–6508.
133. Wang H.J., Kuo C.H., Yeh A.A.M., Chang P.C.L., Wang W.C. Vacuolating toxin production in clinical isolates of Helicobacter pylori with different vacA genotypes. J. Infect. Dis. 1998;178:207–212.
134. Basso D., Zambon C.F., Letley D.P., Stranges A., Marchet A., Rhead J.L., Schiavon S., Guariso G., Ceroti M., Nitti D., et al. Clinical Relevance of Helicobacter pylori cagA and vacA Gene Polymorphisms. Gastroenterology. 2008;135:91–99.
135. Nogueira C., Figueiredo C., Carneiro F., Gomes A.T., Barreira R., Figueira P., Salgado C., Belo L., Peixoto A., Bravo J.C., et al. Helicobacter pylori genotypes may determine gastric histopathology. Am. J. Pathol. 2001;158:647–654.
136. Sugimoto M., Zali M.R., Yamaoka Y. The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East. Eur. J. Clin. Microbiol. Infect. Dis. 2009;28:1227–1236.
137. Chang W.L., Yeh Y.C., Sheu B.S. The impacts of H. pylori virulence factors on the development of gastroduodenal diseases. J. Biomed. Sci. 2018;25:68.
138. Chung C., Olivares A., Torres E., Yilmaz O., Cohen H., Perez-Perez G. Diversity of VacA intermediate region among Helicobacter pylori strains from several regions of the world 1. J. Clin. Microbiol. 2010;48:690–696.
139. Ji X., Fernandez T., Burroni D., Pagliaccia C., Atherton J.C., Reyrat J.M., Rappuoli R., Telford J.L. Cell specificity of Helicobacter pylori cytotoxin is determined by a short region in the polymorphic midregion. Infect. Immun. 2000;68:3754–3757.
140. Weiss G., Forster S., Irving A., Tate M., Ferrero R.L., Hertzog P., Frøkiær H., Kaparakis-Liaskos M. Helicobacter pylori VacA Suppresses Lactobacillus acidophilus-Induced Interferon Beta Signaling in Macrophages via Alterations in the Endocytic Pathway. mBio. 2013;4:e00609-12
141. Zheng P.Y., Jones N.L. Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell Microbiol. 2003;5:25–40.
142. Jung M.K., Joo S.K., Jin Y.L., Kim Y.J., Youn H.J., In Y.K., Young J.C., Oh Y.K., Kim N., Hyun C.J., et al. Vacuolating Cytotoxin in Helicobacter pylori Water-Soluble Proteins Upregulates Chemokine Expression in Human Eosinophils via Ca2+ Influx, Mitochondrial Reactive Oxygen Intermediates, and NF-κB Activation. Infect. Immun. 2007;75:3373–3381.
143. Supajatura V., Ushio H., Wada A., Yahiro K., Okumura K., Ogawa H., Hirayama T., Ra C. Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J. Immunol. 2002;168:2603–2607.
144. Oertli M., Noben M., Engler D.B., Semper R.P., Reuter S., Maxeiner J., Gerhard M., Taube C., Muller A. Helicobacter pylori gamma-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance. Proc. Natl. Acad. Sci. USA. 2013;110:3047–3052.
145. Boncristiano M., Paccani S.R., Barone S., Ulivieri C., Patrussi L., Ilver D., Amedei A., D’Elios M.M., Telford J.L., Baldari C.T. The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J. Exp. Med. 2003;198:1887–1897.
146. Gebert B., Fischer W., Weiss E., Hoffmann R., Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science. 2003;301:1099–1102.
147. Molinari M., Salio M., Galli C., Norais N., Rappuoli R., Lanzavecchia A., Montecucco C. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin vacA. J. Exp. Med. 1998;187:135–140.
148. Allen L.A., Schlesinger L.S., Kang B. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J. Exp. Med. 2000;191:115–128.
149. Zanotti G., Papinutto E., Dundon W.G., Battistutta R., Seveso M., Giudice G., Del Rappuoli R., Montecucco C. Structure of the neutrophil-activating protein from Helicobacter pylori. J. Mol. Biol. 2002;323:125–130.
150. Satin B., Del G.G., Della V.B., Dusi S., Laudanna C., Tonello F., Kelleher D., Rappuoli R., Montecucco C., Rossi F. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J. Exp. Med. 2000;191:1467–1476.
151. Evans D.J., Jr., Evans D.G., Takemura T., Nakano H., Lampert H.C., Graham D.Y., Granger D.N., Kvietys P.R. Characterization of a Helicobacter pylori neutrophil-activating protein. Infect. Immun. 1995;63:2213–2220.
152. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis. 2000;21:361–370.
153. Fu H.W. Helicobacter pylori neutrophil-activating protein: From molecular pathogenesis to clinical applications. World J. Gastroenterol. 2014;20:5294–5301.
154. Montemurro P., Nishioka H., Dundon W.G., de Bernard M., Del G.G., Rappuoli R., Montecucco C. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells. Eur. J. Immunol. 2002;32:671–676.
155. Polenghi A., Bossi F., Fischetti F., Durigutto P., Cabrelle A., Tamassia N., Cassatella M.A., Montecucco C., Tedesco F., de Bernard M. The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo. J. Immunol. 2007;178:1312–1320.
156. Wen S.H., Hong Z.W., Chen C.C., Chang H.W., Fu H.W. Helicobacter pylori neutrophil-activating protein directly interacts with and activates toll-like receptor 2 to induce the secretion of interleukin-8 from neutrophils and atra-induced differentiated hl-60 cells. Int. J. Mol. Sci. 2021;22:11560.
157. Castanheira F.V.S., Kubes P. Neutrophils and NETs in modulating acute and chronic inflammation. Blood Content Repos. 2019;133:2178–2185.
158. Oleastro M., Ménard A. The role of Helicobacter pylori outer membrane proteins in adherence and pathogenesis. Biology. 2013;2:1110–1134.
159. Huang T., Zhou F., Yuan X., Yang T., Liang X., Wang Y., Tu H., Chang J., Nan K., Wei Y. Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway. Oxidative Med. Cell. Longev. 2019;2019:5813985.
160. Ramachandran M., Jin C., Yu D., Eriksson F., Essand M. Vector-Encoded Helicobacter pylori Neutrophil-Activating Protein Promotes Maturation of Dendritic Cells with Th1 Polarization and Improved Migration. J. Immunol. 2014;193:2287–2296.
161. Rossi M., Bolz C., Revez J., Javed S., El-Najjar N., Anderl F., Hyytiäinen H., Vuorela P., Gerhard M., Hänninen M.L. Evidence for conserved function of γ-glutamyltranspeptidase in Helicobacter genus. PLoS ONE. 2012;7:e30543.
162. Saini M., Kashyap A., Bindal S., Saini K., Gupta R. Bacterial Gamma-Glutamyl Transpeptidase, an Emerging Biocatalyst: Insights Into Structure–Function Relationship and Its Biotechnological Applications. Front. Microbiol. 2021;2021:641251.
163. Shibayama K., Wachino J.I., Arakawa Y., Saidijam M., Rutherford N.G., Henderson P.J.F. Metabolism of glutamine and glutathione via gamma-glutamyltranspeptidase and glutamate transport in Helicobacter pylori: Possible significance in the pathophysiology of the organism. Mol. Microbiol. 2007;64:396–406.
164. McGovern K.J., Blanchard T.G., Gutierrez J.A., Czinn S.J., Krakowka S., Youngman P. γ-glutamyltransferase is a Helicobacter pylori virulence factor but is not essential for colonization. Infect. Immun. 2001;69:4168–4173.
165. Chevalier C., Thiberge J.M., Ferrero R.L., Labigne A. Essential role of Helicobacter pylori gamma-glutamyltranspeptidase for the colonization of the gastric mucosa of mice. Mol. Microbiol. 1999;31:1359–1372.
166. Kim K.M., Lee S.G., Park M.G., Song J.Y., Kang H.L., Lee W.K., Cho M.J., Rhee K.H., Youn H.S., Baik S.C. Gamma-glutamyltranspeptidase of Helicobacter pylori induces mitochondria-mediated apoptosis in AGS cells. Biochem. Biophys. Res. Commun. 2007;355:562–567.
167. Valenzuela M., Bravo D., Canales J., Sanhueza C., Díaz N., Almarza O., Toledo H., Quest A.F.G. Helicobacter pylori-induced loss of survivin and gastric cell viability is attributable to secreted bacterial gamma-glutamyl transpeptidase activity. J. Infect. Dis. 2013;208:1131–1141.
168. Kim K.M., Lee S.G., Kim J.M., Kim D.S., Song J.Y., Kang H.L., Lee W.K., Cho M.J., Rhee K.H., Youn H.S., et al. Helicobacter pylori γ-glutamyltranspeptidase induces cell cycle arrest at the G1-S phase transition. J. Microbiol. 2010;48:372–377.
169. Gong M., Ling S.S.M., Lui S.Y., Yeoh K.G., Ho B. Helicobacter pylori γ-glutamyl transpeptidase is a pathogenic factor in the development of peptic ulcer disease. Gastroenterology. 2010;139:564–573.
170. Busiello I., Acquaviva R., Di Popolo A., Blanchard T.G., Ricci V., Romano M., Zarrilli R. Helicobacter pylori γ-glutamyltranspeptidase upregulates COX-2 and EGF-related peptide expression in human gastric cells. Cell Microbiol. 2004;6:255–267.
171. Nagy T.A., Frey M.R., Yan F., Israel D.A., Polk D.B., Peek R.M. Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J. Infect. Dis. 2009;199:641–651.
172. Murayama Y., Miyagawa J.I., Shinomura Y., Kanayama S., Isozaki K., Yamamori K., Mizuno H., Ishiguro S., Kiyohara T., Miyazaki Y., et al. Significance of the association between heparin-binding epidermal growth factor-like growth factor and CD9 in human gastric cancer. Int. J. Cancer. 2002;98:505–513.
173. Yin F., Grabowska A.M., Clarke P.A., Whelband E., Robinson K., Argent R.H., Tobias A., Kumari R., Atherton J.C., Watson S.A. Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: Links to soluble HB-EGF, gastrin and matrix metalloproteinase-7. Gut. 2010;59:1037–1045.
174. Shi H., Qi C., Meng L., Yao H., Jiang C., Fan M., Zhang Q., Hou X., Lin R. Bone marrow-derived mesenchymal stem cells promote Helicobacter pylori-associated gastric cancer progression by secreting thrombospondin-2. Cell Prolif. 2021;54:e13114.
175. Wang Z., Wang W., Shi H., Meng L., Jiang X., Pang S., Fan M., Lin R. Gamma-glutamyltransferase of Helicobacter pylori alters the proliferation, migration, and pluripotency of mesenchymal stem cells by affecting metabolism and methylation status. J. Microbiol. 2022;60:627–639.
176. Meng L., Shi H., Wang Z., Fan M., Pang S., Lin R. The Gamma-glutamyltransferase gene of Helicobacter pylori can promote gastric carcinogenesis by activating Wnt signal pathway through up-regulating TET1. Life Sci. 2021;267:118921.
177. Schmees C., Prinz C., Treptau T., Rad R., Hengst L., Voland P., Bauer S., Brenner L., Schmid R.M., Gerhard M. Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase. Gastroenterology. 2007;132:1820–1833.
178. Gerhard M., Schmees C., Voland P., Endres N., Sander M., Reindl W., Rad R., Oelsner M., Decker T., Mempel M., et al. A secreted low-molecular-weight protein from Helicobacter pylori induces cell-cycle arrest of T cells. Gastroenterology. 2005;128:1327–1339.
179. Fassi Fehri L., Koch M., Belogolova E., Khalil H., Bolz C., Kalali B., Mollenkopf H.J., Beigier-Bompadre M., Karlas A., Schneider T., et al. Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent manner. PLoS ONE. 2010;5:e9500.
180. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–1061.
181. Kandulski A., Wex T., Kuester D., Peitz U., Gebert I., Roessner A., Malfertheiner P. Naturally occurring regulatory T cells (CD4+, CD25high, FOXP3+) in the antrum and cardia are associated with higher H. pylori colonization and increased gene expression of TGF-beta1. Helicobacter. 2008;13:295–303.
182. Ohue Y., Nishikawa H. Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? Cancer Sci. 2019;110:2080–2089.
183. Lina T.T., Alzahrani S., House J., Yamaoka Y., Sharpe A.H., Rampy B.A., Pinchuk I.V., Reyes V.E. Helicobacter pylori cag pathogenicity island’s role in B7-H1 induction and immune evasion. PLoS ONE. 2015;10:e0121841.
184. Das S., Suarez G., Beswick E.J., Sierra J.C., Graham D.Y., Reyes V.E. Expression of B7-H1 on gastric epithelial cells: Its potential role in regulating T cells during Helicobacter pylori infection. J. Immunol. 2006;176:3000–3009.
185. Beswick E.J., Pinchuk I.V., Das S., Powell D.W.W., Reyes V.E.E. B7-H1 Expression on Gastric Epithelial Cells after Helicobacter pylori Exposure Promotes the Development of CD4+ CD25+ FoxP3+ Regulatory T Cells. Infect. Immun. 2007;75:4334–4341.
186. Xie G., Li W., Li R., Wu K., Zhao E., Zhang Y., Zhang P., Shi L., Wang D., Yin Y., et al. Helicobacter pylori Promote B7-H1 Expression by Suppressing miR-152 and miR-200b in Gastric Cancer Cells. PLoS ONE. 2017;12:e0168822.
187. Wu J., Zhu X., Guo X., Yang Z., Cai Q., Gu D., Luo W., Yuan C., Xiang Y. Helicobacter urease suppresses cytotoxic CD8+ T-cell responses through activating Myh9-dependent induction of PD-L1. Int. Immunol. 2021;33:491–504.
188. Lina T.T., Pinchuk I.V., House J., Yamaoka Y., Graham D.Y., Beswick E.J., Reyes V.E. CagA-dependent downregulation of B7-H2 expression on gastric mucosa and inhibition of Th17 responses during Helicobacter pylori infection. J. Immunol. 2013;191:3838–3846.
189. Hou J., Yu Z., Xiang R., Li C., Wang L., Chen S., Li Q., Chen M., Wang L. Correlation between infiltration of FOXP3+ regulatory T cells and expression of B7-H1 in the tumor tissues of gastric cancer. Exp. Mol. Pathol. 2014;96:284–291.
190. Shigemori T., Toiyama Y., Okugawa Y., Yamamoto A., Yin C., Narumi A., Ichikawa T., Ide S., Shimura T., Fujikawa H., et al. Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression. Ann. Surg. Oncol. 2019;26:876–883.
191. Böger C., Behrens H.M., Krüger S., Röcken C., Boger C., Behrens H.M., Kruger S., Rocken C. The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy? Oncoimmunology. 2017;6:e1293215.
192. Lina T.T., Gonzalez J., Pinchuk I.V., Beswick E.J., Reyes V.E. Helicobacter pylori Elicits B7-H3 Expression on Gastric Epithelial Cells: Implications in Local T Cell Regulation and Subset Development During Infection. Clin. Oncol. Res. 2019;2:1–12.
(Hết)
TS.BS. Huỳnh Hồng Quang & Ths.Bs. Châu Văn Khánh
Viện Sốt rét-KST-CT Quy Nhơn